LBX2 and ovarian carcinoma: In this research, we found that, based on the data we obtained from TCGA database and our clinical record, the expression level of LBX2‐AS1 was frequently increased in ovarian cancer, and patients who have high LBX2‐AS1 expression levels in their ovarian cancer tissue specimens showed a decreased overall survival, suggesting the cancer‐promoting role of this lncRNA in ovarian cancer.